Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
5 things to know before the stock market opens Monday
Tags Business News Novo Nordisk A/S United Parcel Service Inc
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Merck & Co Inc Moderna Inc Companies
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Zealand Pharma A/S Viking Therapeutics Inc Sanofi SA
From CNBC.com News
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
Tags stocks Novo Nordisk A/S Nestle SA
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
Tags Breaking News: Politics AstraZeneca PLC Novartis AG
From CNBC.com News
Here are the big health sector themes to watch next year
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Business News
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Amgen Inc Companies Pfizer Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Technology Pfizer Inc Economy
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Pfizer Inc Health care industry AstraZeneca PLC
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
Tags Health & Science Business Biotechnology
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
Tags Breaking News: Politics Europe Economy Breaking News: Economy
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Investment strategy Tyson Foods Inc Markets
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Health & Science Biotechnology Business
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Business News Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Biotechnology Business Health & Science
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags Novo Nordisk A/S Stock Picks stocks
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Pfizer Inc Health care industry Companies
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Gap Inc 5 Things to Know Markets
From CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
Tags Business Social issues Health & Science
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
Tags Investment Strategy Walmart Inc Macy's Inc
From CNBC.com News
Cramer's Lightning Round: Buy AutoZone
Tags Dream Finders Homes Inc Investment strategy Markets
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
Tags Health care industry Breaking news Companies
From CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Tags Novo Nordisk A/S Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Business News Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
Tags US Top News and Analysis Business News Europe News
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Novo Nordisk A/S Breaking News: Earnings Biotech and Pharmaceuticals
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags COVID/19 Business Biotechnology
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Health care industry Dexcom Inc Technology
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.